Literature DB >> 35114754

Superscan Appearance of 68Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer.

Zehra Pınar Koç1, Pınar Pelin Özcan1, Vehbi Erçolak2, Mehmet Reyhan3.   

Abstract

A 64-year-old male patient with metastatic prostate carcinoma diagnosis received lutetium-177 prostate-specific membrane antigen (PSMA) treatment; however, his disease progressed. Herein, presented the final images of the patient that demonstrated a superscan appearance in the Gallium-68 PSMA positron emission tomography/computed tomography, which is a rare phenomenon.

Entities:  

Keywords:  68Ga; Lu-177; PSMA; prostate cancer

Year:  2022        PMID： 35114754      PMCID： PMC8814547          DOI： 10.4274/mirt.galenos.2020.78800

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN： 2146-1414


  8 in total

1.  18F-FDG PET/CT superscan in prostate cancer.

Authors:  Matthieu Bailly; Hélène Besse; Rémi Kerdraon; Gilles Metrard; Sabine Gauvain
Journal:  Clin Nucl Med       Date:  2014-10       Impact factor: 7.794

2.  Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.

Authors:  Mico Chan; Geoffrey Paul Schembri
Journal:  Clin Nucl Med       Date:  2017-02       Impact factor: 7.794

3.  Metabolic Skeletal Superscan on 18F-FDG PET/CT in a Case of Acute Lymphoblastic Leukemia.

Authors:  Girish Kumar Parida; Ramya Soundararajan; Averilicia Passah; Chandrasekhar Bal; Rakesh Kumar
Journal:  Clin Nucl Med       Date:  2015-07       Impact factor: 7.794

4.  Secondary Hyperparathyroidism With "Superscan-Like" Hypermetabolic FDG PET/CT Pattern.

Authors:  Jean-Francois Grellier; David Lussato; Mathieu Queneau; Mohamed Guernou; Bernard Songy
Journal:  Clin Nucl Med       Date:  2015-11       Impact factor: 7.794

5.  Metabolic super scan in F-FDG PET/CT imaging.

Authors:  Dae-Weung Kim; Chang Guhn Kim; Soon-Ah Park; Sang-Ah Jung; Sei-Hoon Yang
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

6.  Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.

Authors:  Teik Hin Tan; Teck Huat Wong; Siti Zarina Amir Hassan; Boon Nang Lee
Journal:  Clin Nucl Med       Date:  2015-11       Impact factor: 7.794

7.  Absent or faint renal uptake on bone scan. Etiology and significance in metastatic bone disease.

Authors:  S E Kim; D Y Kim; D S Lee; J K Chung; M C Lee; C S Koh
Journal:  Clin Nucl Med       Date:  1991-08       Impact factor: 7.794

8.  Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan.

Authors:  Krishan Kant Agarwal; Madhavi Tripathi; Rajeev Kumar; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.